# Mingtai Pharmaceutical Investment

Mingtai Pharmaceutical Investment is a Private Equity based in Taizhou, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Taizhou, China
- **Region:** Asia
- **Address:** Taizhou, China
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Mingtai Pharmaceutical Investment is a private equity firm based in Taizhou, China. It focuses on venture capital investments.

## Sectors

- Pharma & Biotech
- Healthcare Services

## Questions

### What is Mingtai Pharmaceutical Investment's investment strategy?

The firm deploys a two-layered strategy within the pharmaceutical and healthcare sectors. It makes direct venture capital investments across seed, start-up, and general venture stages, and operates a parallel fund-of-funds program that commits capital to external healthcare-specialist fund managers. This structure combines concentrated single-company bets with diversified exposure through third-party funds.

### Who runs investment decisions at Mingtai Pharmaceutical Investment?

The firm does not publicly name its principals, investment committee members, or senior deal leads on a website or LinkedIn presence. For a healthcare-first fund in China, verifying the scientific or clinical-operating background of the decision-makers — and whether they come from pharma R&D, regulatory bodies, or pure finance — is a basic threshold item for any institutional allocator or co-investor.

## Related profiles

- [Mingshi Investment Management](https://altss.com/profile/mingshi-investment-management)
- [Minhe Capital](https://altss.com/profile/minhe-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mingtai-pharmaceutical-investment

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology